Alnylam Pharmaceuticals shares owned by Rafferty Asset Management
Quarter-by-quarter ownership of Alnylam Pharmaceuticals (ALNY) shares owned by Rafferty Asset Management
from 13F filings
Historical chart of Rafferty Asset Management investment in Alnylam Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Alnylam Pharmaceuticals held by Rafferty Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Alnylam Pharmaceuticals by Rafferty Asset Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $7.8M | 17k | 456.00 |
| 2025-06-30 | $11M | 32k | 326.09 |
| 2025-03-31 | $12M | 45k | 270.02 |
| 2024-12-31 | $12M | 53k | 235.31 |
| 2024-09-30 | $18M | 64k | 275.03 |
| 2024-03-31 | $9.1M | 61k | 149.45 |
| 2023-09-30 | $7.8M | 44k | 177.10 |
| 2023-06-30 | $8.3M | 44k | 189.94 |
| 2023-03-31 | $7.7M | 38k | 200.32 |
| 2022-12-31 | $8.6M | 36k | 237.65 |
| 2022-09-30 | $6.6M | 33k | 200.17 |
| 2022-06-30 | $4.5M | 31k | 145.85 |
| 2022-03-31 | $6.0M | 37k | 163.28 |
| 2021-12-31 | $5.4M | 32k | 169.57 |
| 2021-09-30 | $3.1M | 16k | 188.80 |
| 2021-06-30 | $2.7M | 16k | 169.52 |
| 2021-03-31 | $3.3M | 23k | 141.20 |
| 2020-12-31 | $934k | 7.2k | 129.92 |
| 2020-09-30 | $2.4M | 16k | 145.63 |
| 2020-06-30 | $1.5M | 9.9k | 148.14 |
| 2020-03-31 | $444k | 4.1k | 108.82 |
| 2019-12-31 | $3.9M | 34k | 115.17 |
| 2019-09-30 | $6.2M | 78k | 80.41 |
| 2019-06-30 | $5.1M | 71k | 72.57 |
| 2019-03-31 | $5.6M | 60k | 93.44 |